STATIN SAFETY REVISITED DATA

Abstract

Questions of statins use in liver diseases are discussed. Data from clinical studies on statins safety in cardiac patients with liver diseases are presented. Features of statins use in nonalcoholic fatty liver disease, viral hepatitis C are considered separately.

Keywords

• статины
• сердечно-сосудистые заболевания
• неалкогольная жировая болезнь печени
• неалкогольный стеатогепатит
• вирусный гепатит С